Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland

J Comput Assist Tomogr. 1988 Sep-Oct;12(5):728-35. doi: 10.1097/00004728-198809010-00002.

Abstract

Gadolinium diethylenetriamine pentaacetic acid (DTPA) enhanced magnetic resonance imaging was performed in eight patients with Cushing disease and surgically proven pituitary microadenomas. A 1.5 T scanner was used with 3 mm contiguous slices. Short repetition times (TR), short echo times (TE), and long TR, long TE sequences were obtained before and serially after intravenous administration of Gd-DTPA. Three of eight (38%) microadenomas were undetectable both without and with Gd-DTPA: one post-Gd-DTPA scan was false positive on the side opposite the adenoma. Hemihypophysectomy based on a petrosal sinus adrenocorticotropic hormone (ACTH) gradient cured all three patients. Two microadenomas (25%) were visible as hypointense foci following Gd-DTPA but not on unenhanced scans. The remaining three microadenomas (38%) were seen before and after Gd-DTPA on T1-weighted images. In this small series of ACTH-producing microadenomas, one-third were seen on unenhanced 1.5 T scans, one-third were seen only after Gd-DTPA, and one-third were not imaged even with Gd-DTPA enhancement.

MeSH terms

  • Adenoma / diagnosis*
  • Adult
  • Contrast Media*
  • Female
  • Gadolinium DTPA
  • Humans
  • Image Enhancement / methods*
  • Magnetic Resonance Imaging / methods*
  • Middle Aged
  • Organometallic Compounds*
  • Pentetic Acid*
  • Pituitary Neoplasms / diagnosis*
  • Predictive Value of Tests

Substances

  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium DTPA